The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 05, 2026
Filed:
Sep. 13, 2021
Bar Ilan University, Ramat Gan, IL;
Université DE Montréal, Montréal, CA;
Societe DE Commercialisation Des Produits DE LA Recherche Appliquee Socpra Sci, Sherbrooke, CA;
Shai Rahimipour, Ramat Gan, IL;
Maram Habashi, Ramat Gan, IL;
Michal Richman, Ramat Gan, IL;
William Lubell, Québec, CA;
Pradeep Chauhan, Montréal, CA;
Suresh Vutla, Montréal, CA;
Ramesh Chingle, Frederick, MD (US);
Samia Ait-Mohand, Sherbrooke, CA;
Veronique Dumulon-Perreault, Sherbrooke, CA;
Brigitte Guerin, Westbury, CA;
BAR ILAN UNIVERSITY, Ramat Gan, IL;
UNIVERSITÉ DE MONTRÉAL, Montréal, CA;
SOCIÉTÉ DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUÉE SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C., Sherbrooke, CA;
Abstract
Described herein are synthetic cyclic peptide mimetics comprising alternating D-amino acids and L-amino acids and amino acid derivatives, such as aza-amino acids and azasulfuryl-amino acids. Optionally, the cyclic peptide mimetics may be conjugated to another agent via a linker to form cyclic peptide mimetic conjugates. The cyclic peptide mimetics described herein may be used as diagnostic or therapeutic agents for diagnosis or treatment of amyloidogenic diseases.